1.
Ginter E, Simko V: Type 2 diabetes mellitus, pandemic in 21st century. Advances in experimental medicine and biology 2012, 771:42-50.
2.
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda
B: IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections
for 2045. Diabetes research and clinical practice 2018, 138:271-281.
3.
Nejatian N, Hafner AK, Shoghi F, Badenhoop K, Penna-Martinez M: 5-Lipoxygenase (ALOX5): Genetic susceptibility to type 2 diabetes and vitamin D effects
on monocytes. The Journal of steroid biochemistry and molecular biology 2019, 187:52-57.
4.
Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle
A, Hadjadj S et al: A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445(7130):881-885.
5.
Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry
JR, Rayner NW, Freathy RM et al: Replication of genome-wide association signals in UK samples reveals risk loci for
type 2 diabetes. Science (New York, NY) 2007, 316(5829):1336-1341.
6.
van Hoek M, Dehghan A, Witteman JC, van Duijn CM, Uitterlinden AG, Oostra BA, Hofman
A, Sijbrands EJ, Janssens AC: Predicting type 2 diabetes based on polymorphisms from genome-wide association studies:
a population-based study. Diabetes 2008, 57(11):3122-3128.
7.
Schroeder BC, Waldegger S, Fehr S, Bleich M, Warth R, Greger R, Jentsch TJ: A constitutively open potassium channel formed by KCNQ1 and KCNE3. Nature 2000, 403(6766):196-199.
8.
Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H, Hirota Y, Mori H, Jonsson
A, Sato Y et al: Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nature genetics 2008, 40(9):1092-1097.
9.
Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, Andersen G, Ng DP, Holmkvist
J, Borch-Johnsen K, Jorgensen T et al: SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian
and European populations. Nature genetics 2008, 40(9):1098-1102.
10.
Ullrich S, Su J, Ranta F, Wittekindt OH, Ris F, Rosler M, Gerlach U, Heitzmann D,
Warth R, Lang F: Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells. Pflugers Archiv : European journal of physiology 2005, 451(3):428-436.
11.
Liu L, Wang F, Lu H, Ren X, Zou J: Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin
secretion and increases glucagon-like peptide-1 level in mice. Islets 2014, 6(4):e962386.
12.
Boini KM, Graf D, Hennige AM, Koka S, Kempe DS, Wang K, Ackermann TF, Foller M, Vallon
V, Pfeifer K et al: Enhanced insulin sensitivity of gene-targeted mice lacking functional KCNQ1. American journal of physiology Regulatory, integrative and comparative physiology
2009, 296(6):R1695-1701.
13.
Hu C, Wang C, Zhang R, Ma X, Wang J, Lu J, Qin W, Bao Y, Xiang K, Jia W: Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in
a Chinese population. Diabetologia 2009, 52(7):1322-1325.
14.
Lin YD, Qian Y, Dong MH, Lu F, Shen C, Jin GF, Hu ZB, Shen HB: [Association of polymorphisms of potassium voltage-gated channel, KQT-like subfamily,
member 1 and type 2 diabetes in Jiangsu province, China]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2013, 47(6):538-541.
15.
Wang H, Miao K, Zhao J, Liu L, Cui G, Chen C, Wang DW, Ding H: Common variants in KCNQ1 confer increased risk of type 2 diabetes and contribute to
the diabetic epidemic in East Asians: a replication and meta-analysis. Annals of human genetics 2013, 77(5):380-391.
16.
Gabriel S, Ziaugra L, Tabbaa D: SNP genotyping using the Sequenom MassARRAY iPLEX platform. Current protocols in human genetics 2009, Chapter 2:Unit 2.12.
17.
Liu X, Huang X, Zhang S, Niu F, Ouyang Y, Shou Z, Liu J: Correlations between CYP3A4 polymorphism and susceptibility to breast cancer in Chinese
Han population. International journal of clinical oncology 2019, 24(2):179-188.
18.
Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W,
Zander T, MacConaill L et al: High-throughput oncogene mutation profiling in human cancer. Nature genetics 2007, 39(3):347-351.
19.
An F, Wang J, Gao H, Liu C, Tian Y, Jin T, Liu W, Wang J: Impact of IL1R1 and IL1R2 gene polymorphisms on risk of osteonecrosis of the femoral
head from a case-control study. Molecular genetics & genomic medicine 2019:e00557.
20.
Jonsson A, Isomaa B, Tuomi T, Taneera J, Salehi A, Nilsson P, Groop L, Lyssenko V:
A variant in the KCNQ1 gene predicts future type 2 diabetes and mediates impaired
insulin secretion. Diabetes 2009, 58(10):2409-2413.
21.
Mussig K, Staiger H, Machicao F, Haring HU, Fritsche A: Genetic variants affecting incretin sensitivity and incretin secretion. Diabetologia 2010, 53(11):2289-2297.
22.
Saif-Ali R, Muniandy S, Al-Hamodi Z, Lee CS, Ahmed KA, Al-Mekhlafi AM, Ismail IS:
KCNQ1 variants associate with type 2 diabetes in Malaysian Malay subjects. Annals of the Academy of Medicine, Singapore 2011, 40(11):488-492.
23.
Tsai FJ, Yang CF, Chen CC, Chuang LM, Lu CH, Chang CT, Wang TY, Chen RH, Shiu CF,
Liu YM et al: A genome-wide association study identifies susceptibility variants for type 2 diabetes
in Han Chinese. PLoS genetics 2010, 6(2):e1000847.
24.
Liu Y, Zhou DZ, Zhang D, Chen Z, Zhao T, Zhang Z, Ning M, Hu X, Yang YF, Zhang ZF et al: Variants in KCNQ1 are associated with susceptibility to type 2 diabetes in the population
of mainland China. Diabetologia 2009, 52(7):1315-1321.
25.
Been LF, Ralhan S, Wander GS, Mehra NK, Singh J, Mulvihill JJ, Aston CE, Sanghera
DK: Variants in KCNQ1 increase type II diabetes susceptibility in South Asians: a study
of 3,310 subjects from India and the US. BMC medical genetics 2011, 12:18.
26.
Tan JT, Nurbaya S, Gardner D, Ye S, Tai ES, Ng DP: Genetic variation in KCNQ1 associates with fasting glucose and beta-cell function:
a study of 3,734 subjects comprising three ethnicities living in Singapore. Diabetes 2009, 58(6):1445-1449.
27.
Riobello C, Gomez J, Gil-Pena H, Tranche S, Reguero JR, de la Hera JM, Delgado E,
Calvo D, Moris C, Santos F et al: KCNQ1 gene variants in the risk for type 2 diabetes and impaired renal function in
the Spanish Renastur cohort. Molecular and cellular endocrinology 2016, 427:86-91.
28.
Turki A, Mtiraoui N, Al-Busaidi AS, Khirallah M, Mahjoub T, Almawi WY: Lack of association between genetic polymorphisms within KCNQ1 locus and type 2 diabetes
in Tunisian Arabs. Diabetes research and clinical practice 2012, 98(3):452-458.
29.
Dobrikova M, Javorsky M, Habalova V, Klimcakova L, Kozarova M, Zidzik J, Haluskova
J, Salagovic J, Tkac I: [Relationship of the CDKAL1 and KCNQ1 gene polymorphisms to the age at diagnosis of
type 2 diabetes in the Slovakian population]. Vnitrni lekarstvi 2011, 57(2):155-158.
30.
Kim J, Kim MK, Jung S, Lim JE, Shin MH, Kim YJ, Oh B: Interaction of iron status with single nucleotide polymorphisms on incidence of type
2 diabetes. PloS one 2017, 12(4):e0175681.
31.
Jadhav RA, Hazari A, Monterio A, Kumar S, Maiya AG: Effect of Physical Activity Intervention in Prediabetes: A Systematic Review With
Meta-analysis. Journal of physical activity & health 2017, 14(9):745-755.
32.
Ligthart S, Steenaard RV, Peters MJ, van Meurs JB, Sijbrands EJ, Uitterlinden AG,
Bonder MJ, Hofman A, Franco OH, Dehghan A: Tobacco smoking is associated with DNA methylation of diabetes susceptibility genes. Diabetologia 2016, 59(5):998-1006.
33.
George AM, Jacob AG, Fogelfeld L: Lean diabetes mellitus: An emerging entity in the era of obesity. World journal of diabetes 2015, 6(4):613-620.
34.
Kong X, Xing X, Hong J, Zhang X, Yang W: Genetic variants associated with lean and obese type 2 diabetes in a Han Chinese population:
A case-control study. Medicine 2016, 95(23):e3841.